<DOC>
	<DOCNO>NCT02071628</DOCNO>
	<brief_summary>This study design validation in-vitro platelet aggregation assay use human blood healthy volunteer . 32ml blood , 2ml complete blood count test 30ml platelet aggregation assay , collect ten subject , respectively . Preparation Platelet Rich Plasma ( PRP ) : 1 . Collect human blood use 21g butterfly syringe dilute 9:1 3.8 % sodium citrate vacutainer vial . 2 . Prepare platelet rich plasma ( PRP ) centrifuge blood 100 x g 15 minute room temperature . Using plastic transfer pipette , carefully transfer combine PRP multiple vacutainer tube ( require ) 15 mL conical tube . 3 . PRP remove re-centrifuge remain blood vacutainer tube 2000 x g 15 minute room temp . obtain platelet poor plasma ( PPP ) . Transfer PPP 15 mL conical tube . 4 . Measure platelet count combine PRP use Z1 Coulter Particle Counter similar product . Adjust platelet count final concentration 300,000 +- 10,000 platelet PRP use PPP . Aggregation Measurement : Aggregation measure use model 490-X Chrono-Log Aggregometer similar product . PPP use reference establish 100 % optical transmission .</brief_summary>
	<brief_title>Study Validation In-vitro Turbidometric Platelet Aggregation Assay Using Human Blood Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>2050years old must able consent voluntarily consent keep study term obedience blood coagulation disorder bleed disorder blood donation within 60 day blood transfusion within 30 day screen smoker stop smoke within 1month screen administration drug anticoagulant antiplatelets alcohol within 14 day screen eligibility failure investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>